Home > Balance Sheet > VENUS REMEDIES

VENUS REMEDIES
Contingent Liabilities

    Back to Balance Sheet
COMMUNITY POLL
for VENUS REMEDIES
Please provide your vote to see the results

VENUS REMEDIES Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Contingent Liabilities ₹37 Cr₹40 Cr₹11 Cr₹0.16 Cr₹0.16 Cr

What is the latest Contingent Liabilities ratio of VENUS REMEDIES ?

The latest Contingent Liabilities ratio of VENUS REMEDIES is ₹37 Cr based on Mar2024 Consolidated results.
Year Contingent Liabilities
Mar2024₹37 Cr
Mar2023₹40 Cr
Mar2022₹11 Cr
Mar2021₹0.16 Cr
Mar2020₹0.16 Cr

How is Contingent Liabilities of VENUS REMEDIES Trending?

Years Contingent Liabilities % Change
Mar2024 ₹37 Cr
-5.59
Mar2023 ₹40 Cr
272.42
Mar2022 ₹11 Cr
6,423.93
Mar2021 ₹0.16 Cr
0.00
Mar2020 ₹0.16 Cr -

Compare Contingent Liabilities of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹410.9 Cr 5.3% -10.7% -19.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹427,478.0 Cr -1.3% -4.8% 45% Stock Analytics
DIVIS LABORATORIES ₹163,822.0 Cr 0.5% 6.4% 58.2% Stock Analytics
CIPLA ₹123,920.0 Cr 2.1% 3.8% 24.5% Stock Analytics
DR REDDYS LABORATORIES ₹100,322.0 Cr -0.6% -5.7% 5.7% Stock Analytics
ZYDUS LIFESCIENCES ₹97,217.3 Cr 0.1% -3.6% 48.2% Stock Analytics


VENUS REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

5.3%

-10.7%

-19.6%

SENSEX

0.9%

-0.3%

20.9%


You may also like the below Video Courses